Tumorigenic activity of a rearranged c-<i>myc</i> gene from a human T-cell leukemia line
D. Petroni(University of Milan), Giuseppe Saglio(University of Turin), Paola Comi(University of Milan), Barbára Giglioni, Alessandra Stacchini(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Angelo Guerrasio, Giovanna Martinotti(University of Turin)
Cited by 4
Related Papers
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up
|Leukemia|2012|440
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
|Journal of Clinical Oncology|2009|434
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
|Blood|2013|391
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
|Blood|2001|319
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
|Leukemia|2018|250